FDA approves Aurobindo’s Aygestin generic

DAYTON, N.J. — Aurobindo Pharma announced Wednesday that the Food and Drug Administration had approved its generic of Aygestin (norethindrone acetate) tablets. The drug is indicated to treat secondary amenorrhea, endometriosis and abnormal uterine bleeding. 

 

The tablets will be available in 5-mg dosage strength. The drug had approximately $23.7 million in sales for the 12 months ended November 2015, according to IMS Health.